Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
US Obesity Rates Decline: Are GLP-1 Drugs Like Ozempic & Wegovy the Answer? - Featured image
Weight Loss

US Obesity Rates Decline: Are GLP-1 Drugs Like Ozempic & Wegovy the Answer?

Shotlee Editorial Team
Written by Shotlee Editorial TeamHealth Research & Writing
·November 3, 2025·4 min read

On this page

  • The Numbers: A Promising Trend
  • Understanding GLP-1 Drugs: How They Work
  • Practical Takeaways: What This Means for You
  • Natural Shotlee Integration (if relevant)
  • Conclusion: A Path Forward for Weight Management
  • The Rise of GLP-1 Medications
  • Mechanism of Action

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

New data reveals a drop in US obesity rates, and GLP-1 drugs like Ozempic and Wegovy are likely playing a significant role. This post explores the impact of these medications and what it means for your health.

Share

On this page

  • The Numbers: A Promising Trend
  • Understanding GLP-1 Drugs: How They Work
  • Practical Takeaways: What This Means for You
  • Natural Shotlee Integration (if relevant)
  • Conclusion: A Path Forward for Weight Management
  • The Rise of GLP-1 Medications
  • Mechanism of Action

There's a glimmer of hope in the fight against obesity! Recent survey data indicates a decline in obesity rates in the US, sparking a wave of discussion about the contributing factors. Could GLP-1 drugs, like Ozempic and Wegovy, be a key player in this positive shift? Let's dive into the details and explore what this means for your health and wellness.

The Numbers: A Promising Trend

According to a survey by Gallup, the percentage of obese adults in the US has decreased to 37%, down from a peak of 39.9%. This represents a significant reduction, translating to millions of fewer people classified as obese. This is great news, as it potentially means fewer cases of related health complications like heart disease, stroke, and certain cancers.

This is a positive step forward, but it's essential to remember that obesity remains a serious health concern globally. For instance, the UK reported obesity rates of 28% in 2022, and Australia at 31.7% in 2022-23. The World Health Organization (WHO) defines obesity as a Body Mass Index (BMI) of 30 or higher, calculated based on height and weight.

The Rise of GLP-1 Medications

The survey also highlighted the increasing use of GLP-1 drugs, with usage nearly doubling. These medications, which include semaglutide (Ozempic, Wegovy) and others, have gained considerable attention for their potential to aid weight loss. People are more familiar with these drugs than ever before, which could be part of the reason for the obesity rate decrease.

GLP-1 is a natural hormone that plays a crucial role in regulating appetite, slowing digestion, and managing blood sugar. Medications like Ozempic and Wegovy mimic the action of this hormone, providing a new approach to weight management and overall health improvement. They've also shown potential in impacting metabolic health.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

Understanding GLP-1 Drugs: How They Work

Mechanism of Action

GLP-1 drugs work by activating the same pathways in the brain as the naturally occurring hormone. This leads to a cascade of effects, including reduced appetite, increased feelings of fullness, and improved blood sugar control. Think of it like a remote control for your hunger, helping you feel satisfied with less food.

Semaglutide is one of the more popular GLP-1 agonists, with both Ozempic and Wegovy containing it. Originally designed to treat type 2 diabetes, these medications have proven effective for weight management.

Practical Takeaways: What This Means for You

  • Discuss with your doctor: If you're struggling with weight management, talk to your healthcare provider about whether GLP-1 medications are right for you. They can assess your individual health profile and provide guidance.
  • Focus on lifestyle: Remember that GLP-1 drugs, when used, can be a tool. Combine them with a healthy diet and regular exercise to maximize results.
  • Prioritize metabolic health: Regardless of whether you're using medication, a focus on metabolic health can lead to better health outcomes in general.

Natural Shotlee Integration (if relevant)

Managing weight loss often involves tracking multiple metrics. Tools like Shotlee can help track important data like weight, activity levels, and even food intake, providing valuable insights into your progress. Having access to these key measurements can help you stay on track.

Conclusion: A Path Forward for Weight Management

The recent decline in US obesity rates is encouraging news, suggesting that interventions like GLP-1 medications may be making a difference. While challenges remain, this trend offers a glimpse of hope for improved public health. By understanding the science behind these medications, discussing options with healthcare providers, and adopting a holistic approach to wellness, we can collectively strive towards a healthier future. Remember, it's about making sustainable lifestyle changes and focusing on your overall health and well-being.

Source Information

Originally published by ScienceAlert.Read the original article →

Read next

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

What's the Deal with Peptides? The Hyped Market Under FDA Review
Health & Wellness

What's the Deal with Peptides? The Hyped Market Under FDA Review

An in-depth look at the FDA's review of unregulated peptide therapy, the safety concerns raised by experts, and the conflict between industry demand and clinical evidence.

8 min read
Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program
Health & Wellness

Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program

Learn how the new Medicare GLP-1 Bridge program works, which drugs are covered, and why major pharmaceutical companies are leading the awareness push for the $50 copay initiative.

8 min read
Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials
Medical Research

Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials

Eli Lilly's investigational drug, retatrutide, has shown promising results in clinical trials, offering substantial weight loss and significant improvements in cardiovascular health and type 2 diabetes management.

7 min read

Same topic: GLP-1 drugs

All GLP-1 drugs articles →
Samsung Biologics Acquires PolyPeptide for $1.8 Billion to Expand Peptide Therapeutics
Pharmaceutical Industry News

Samsung Biologics Acquires PolyPeptide for $1.8 Billion to Expand Peptide Therapeutics

Samsung Biologics has announced a major acquisition of PolyPeptide Group AG for $1.8 billion, marking a strategic expansion into the rapidly growing peptide therapeutics market, particularly for GLP-1 drugs.

8 min read
How Iconic Philly Food Brands Are Adapting to Calorie-Conscious Consumers
Health & Wellness

How Iconic Philly Food Brands Are Adapting to Calorie-Conscious Consumers

Philadelphia's iconic food brands are evolving, introducing high-protein and functional food options to cater to the growing number of calorie-conscious consumers, influenced by trends like GLP-1 medications and a desire for healthier choices.

8 min read
Why I Lost Virtually No Weight on Wegovy and Mounjaro
Weight Loss

Why I Lost Virtually No Weight on Wegovy and Mounjaro

Explore the real-world experience of a patient who spent thousands on GLP-1 injections without significant results, and learn what worked instead.

7 min read

More in Weight Loss

GLP-1 Weight Loss & The Changing Landscape: Navigating Semaglutide & Beyond
Weight Loss

GLP-1 Weight Loss & The Changing Landscape: Navigating Semaglutide & Beyond

The GLP-1 weight loss market is experiencing significant shifts with new leadership and competitive pressures. This article dives into the latest developments surrounding semaglutide, Ozempic, and Wegovy, and explores the broader impact on health and wellness.

4 min read
GLP-1 Weight Loss Drugs and the Decline in Obesity: What You Need to Know
Weight Loss

GLP-1 Weight Loss Drugs and the Decline in Obesity: What You Need to Know

New data reveals a drop in obesity rates alongside increased use of GLP-1 weight-loss drugs. This blog explores the connection, offers actionable insights, and discusses the implications for your health and wellness journey.

4 min read
GLP-1 Weight Loss Drugs: Global Expansion & What It Means for Your Health
Weight Loss

GLP-1 Weight Loss Drugs: Global Expansion & What It Means for Your Health

GLP-1 drugs are revolutionizing weight loss globally. This post explores the impact of these medications, their potential benefits beyond weight loss, and how to monitor your health on this journey.

4 min read
Share this article
  1. Home
  2. Blog
  3. US Obesity Rates Decline: Are GLP-1 Drugs Like Ozempic & Wegovy the Answer?
Shotlee Editorial Team — Health Research & Writing
Written by

Shotlee Editorial Team

Health Research & Writing

Shotlee’s guides and articles are researched and written in-house by the Shotlee Editorial Team. We build every page from primary sources — FDA labels, official prescribing information, and peer-reviewed clinical trials — and cite them directly. Our content is educational and is not a substitute for advice from your own healthcare provider.

View all articles by Shotlee Editorial Team
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community